INE351Y01019 beta-drugs-ltd 'Beta Drugs' '1030.00'

Beta Drugs Fundamental Analysis

Beta Drugs NSE

1030.00 00.00 (1.04%) Profit

Open at
Prev Close

Lightning Fast Investing To view real-time data of Beta Drugs and trade with industry first features, Login or Open Free Demat Account. To view real-time data of Beta Drugs and trade with industry first features, Login or Open Free Demat Account.

Company Fundamentals

Company Fundamentals

Company Valuation

Market Cap (Rs Cr.) 985.41
Book Value (Rs) 100.12
Face Value (Rs) 10.00
P/E ratio 52.38
Dividend Yield 0.0 %

Ownership & Shareholding

Company Ownership

Domestic Instituitional Investors
Foreign Instituitional Investors

Shareholding Pattern



Sector Pharmaceuticals
Sub Sector -
Company Classification Smallcap

Exchange Scrips

BSE sec_id
NSE sec_id
ISIN INE351Y01019

Stock Part of Following Indices

Sorry, No information to show at the Moment
Name Current Value Change Change % Open High Low Prev Close

Frequently Asked Questions on Beta Drugs Share

Beta Drugs share has a market capitalization of 985.41 as of today. The share is trading at and has moved by 0.00% in the last year, 0.00% in the last 3 years, and 0.00% in the last 5 years.

Beta Drugs has a P/E ratio of 52.38 as of today. You can check the latest P/E ratio of Beta Drugs and all other listed stocks on Dhan. Open a demat account now!

The ownership stake of Beta Drugs is split as follows:

  • DIIs:
  • FIIs:
  • Promoters:
  • Non-Promoters:

Make informed investing decisions by viewing shareholding patterns on Dhan Stock Trading App or Web Trading Platform Now!

You can use the Dhan App or Web to start fundamental analysis and invest in Beta Drugs share. Begin with free demat account opening and then add money. Search for a stock that you want to analyze, like Beta Drugs. Tap on the “Fundamentals” tab and view all pertinent information in one place.

Beta Drugs Fundamental Analysis Overview

Beta Drugs Fundamental Analysis offers an overview of the company's Market Capitalization, Book Value, P/E Ratio, Dividend Yield and more. It helps to analyse the company's fundamental position and its current shareholding pattern and historical shareholding movement. Presently, the current market cap of Beta Drugs is Rs. 985.41. The Face Value and Book Value per share are Rs. 10.00 and Rs. 100.12 respectively. Current P/E ratio of Beta Drugs stands at 52.38. The promoters holding in the company stands at , while Domestic Institutions stand at 00.00% and Foreign Institutions hold 00.00. While understanding and analysing Fundamentals of a company is very crucial, it is equally important to look at the Share Price, Stock Performance, Financial Statements, Technical Analysis and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.

Download Dhan App

Ready to Trade & Invest in
Beta Drugs?

Get started in 10 minutes or less from here 👇